Objectives: This study examined the reliability and validity of the P-ChIPS in children and adolescents with ASDs. We investigated the agreement between the P-ChIPS and the Child and Adolescent Symptom Inventory (CASI; a parent-completed DSM-IV-based measure of psychiatric disorders) on the assessment of mood, anxiety and disruptive behavior disorders. We will also measure internal consistency and assess interrater reliability.
Methods: The parents of 60 children and adolescents (mean=11.2±3.8 years; range 6-17) with autism, Asperger’s disorder, and PDD-NOS were interviewed with the P-ChIPS and completed the CASI rating scale. The youngsters were administered the Stanford-Binet Intelligence Scales-Fifth Edition, and all had IQs>40. Diagnosis of ASD was confirmed by the Autism Diagnostic Interview-Revised. Agreement between the P-ChIPS and CASI was assessed with kappa statistics and overall agreement. The impact of IQ (IQ>70 vs. IQ<70), age (6-11 vs. 12-17 years), and language (verbal vs. nonverbal) on agreement was also examined by calculating kappa coefficients separately and comparing with z tests.
Results: Diagnostic agreement between P-ChIPS and CSI was higher for the disruptive behavior disorders and for major depression/dysthymia. Kappa statistics range from .20-.56 for the disruptive disorders, indicating fair to moderate agreement. Overall agreement ranged from 65-90%. Kappa statistics for the mood disorders were .35 and .22, indicating fair agreement. Overall agreement was 83% and 78%. Agreement was lower for the anxiety disorders, with most kappa coefficients indicating poor agreement (range .12-.48) and overall agreement ranging from 62%-80%. Age and IQ did not significantly influence kappa statistics.
Conclusions: Kappa statistics and overall agreement was lower than values reported in non-ASD samples. Age and IQ did not appear to impact kappa values. The P-ChIPS shows promise in the population, but may require adaptations for the ASD population.